Blood-brain barrier shuttle platforms Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
11:00
Jan 25
Jan 25
Healthcare money flows to obesity and bispecifics.
At the JP Morgan Healthcare Conference, big M&A was absent but regulatory uncertainty eased, and licensing or technology-transfer money concentrated in bispecific antibodies, blood-brain barrier shuttles, and oral obesity. The speaker says the next cycle is focused on next-generation immuno-oncology, CNS, oral obesity, medical devices, and healthcare AI, making these areas worth remembering.
MED
About Blood-brain barrier shuttle platforms Investor Commentary
Across the available history and selected sources, Buzzberg tracks Blood-brain barrier shuttle platforms across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Choi Chang-gyu.